| Abstrakt: |
A research study conducted by the University of Illinois explores the use of angiotensin II as a vasopressor for perioperative hypotension in solid organ transplant patients. The study highlights the challenges of hypotension during transplantation and the limitations of traditional therapies. Angiotensin II, a novel vasopressor, shows promise in reversing hypotension while potentially avoiding adverse events and complications associated with other agents. Although further investigation is needed, preliminary data suggest that angiotensin II could be a valuable option for transplant patients. [Extracted from the article] |
